People with hATTR amyloidosis who were treated with tafamidis (Vyndamax) have shown improved survival rates. One large study found that nearly 93 percent of people treated with tafamidis were alive after 10 years, compared with 85 percent of those who underwent liver transplantation. Additionally, tafamidis treatment Show Full Answer

People with hATTR amyloidosis who were treated with tafamidis (Vyndamax) have shown improved survival rates. One large study found that nearly 93 percent of people treated with tafamidis were alive after 10 years, compared with 85 percent of those who underwent liver transplantation. Additionally, tafamidis treatment reduced the risk of death by 91 percent in those diagnosed before age 50.

 This AI-generated response comes from MyAmyloidosisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

What’s the Life Expectancy With hATTR Amyloidosis? | MyAmyloidosisTeam

Life Expectancy With Amyloidosis | MyAmyloidosisTeam